Thrombolytic proteins profiling: High‐throughput activity, selectivity, and resistance assays

Cardiovascular diseases, including thrombotic events such as ischemic stroke, pulmonary embolism, and myocardial infarction, are among the leading causes of morbidity and disability worldwide. The application of clot‐dissolving thrombolytic enzymes is a cost‐effective therapeutic intervention for th...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Martin Toul, Alan Strunga, Jiri Damborsky, Zbynek Prokop
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2026-02-01
Edice:	FEBS Open Bio
Témata:	alteplase fibrinolysis PAI‐1 inhibition resistance plasminogen activator staphylokinase tenecteplase
On-line přístup:	https://doi.org/10.1002/2211-5463.70132
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!